Mucopolysaccharidosis II Market - Global Outlook and Forecast 2021-2027

Code: RW00014557519
Market Monitor Global
Oct-2021
Life Sciences
104 Pages

This report contains market size and forecasts of Mucopolysaccharidosis II in global, including the following market information:
Global Mucopolysaccharidosis II Market Revenue, 2016-2021, 2022-2027, ($ millions)
Global Mucopolysaccharidosis II Market Sales, 2016-2021, 2022-2027, (K Pcs)
Global top five Mucopolysaccharidosis II companies in 2020 (%)
The global Mucopolysaccharidosis II market was valued at xx million in 2020 and is projected to reach US$ xx million by 2027, at a CAGR of xx% during the forecast period.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Mucopolysaccharidosis II manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Mucopolysaccharidosis II Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (K Pcs)
Global Mucopolysaccharidosis II Market Segment Percentages, By Type, 2020 (%)
JR-141
EGT-301
DUOC-01
AGT-182
JR-032
Others

Global Mucopolysaccharidosis II Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (K Pcs)
Global Mucopolysaccharidosis II Market Segment Percentages, By Application, 2020 (%)
Hospital
Clinic
Research Center
Others

Global Mucopolysaccharidosis II Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions) & (K Pcs)
Global Mucopolysaccharidosis II Market Segment Percentages, By Region and Country, 2020 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa

Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Mucopolysaccharidosis II revenues in global market, 2016-2021 (Estimated), ($ millions)
Key companies Mucopolysaccharidosis II revenues share in global market, 2020 (%)
Key companies Mucopolysaccharidosis II sales in global market, 2016-2021 (Estimated), (K Pcs)
Key companies Mucopolysaccharidosis II sales share in global market, 2020 (%)
Further, the report presents profiles of competitors in the market, key players include:
Alexion Pharmaceuticals, Inc.
AngioChem Inc.
ArmaGen Inc.
Bioasis Technologies Inc.
Green Cross Corporation
Inventiva
JCR Pharmaceuticals Co., Ltd.
Laboratorios Del Dr. Esteve S.A.
RegenxBio Inc.
Sangamo BioSciences, Inc.
Takeda

Table of Contents

1 Introduction to Research & Analysis Reports
1.1 Mucopolysaccharidosis II Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Mucopolysaccharidosis II Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Mucopolysaccharidosis II Overall Market Size
2.1 Global Mucopolysaccharidosis II Market Size: 2021 VS 2027
2.2 Global Mucopolysaccharidosis II Revenue, Prospects & Forecasts: 2016-2027
2.3 Global Mucopolysaccharidosis II Sales (Consumption): 2016-2027
3 Company Landscape
3.1 Top Mucopolysaccharidosis II Players in Global Market
3.2 Top Global Mucopolysaccharidosis II Companies Ranked by Revenue
3.3 Global Mucopolysaccharidosis II Revenue by Companies
3.4 Global Mucopolysaccharidosis II Sales by Companies
3.5 Global Mucopolysaccharidosis II Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 Mucopolysaccharidosis II Companies in Global Market, by Revenue in 2020
3.7 Global Manufacturers Mucopolysaccharidosis II Product Type
3.8 Tier 1, Tier 2 and Tier 3 Mucopolysaccharidosis II Players in Global Market
3.8.1 List of Global Tier 1 Mucopolysaccharidosis II Companies
3.8.2 List of Global Tier 2 and Tier 3 Mucopolysaccharidosis II Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Mucopolysaccharidosis II Market Size Markets, 2021 & 2027
4.1.2 JR-141
4.1.3 EGT-301
4.1.4 DUOC-01
4.1.5 AGT-182
4.1.6 JR-032
4.1.7 Others
4.2 By Type - Global Mucopolysaccharidosis II Revenue & Forecasts
4.2.1 By Type - Global Mucopolysaccharidosis II Revenue, 2016-2021
4.2.2 By Type - Global Mucopolysaccharidosis II Revenue, 2022-2027
4.2.3 By Type - Global Mucopolysaccharidosis II Revenue Market Share, 2016-2027
4.3 By Type - Global Mucopolysaccharidosis II Sales & Forecasts
4.3.1 By Type - Global Mucopolysaccharidosis II Sales, 2016-2021
4.3.2 By Type - Global Mucopolysaccharidosis II Sales, 2022-2027
4.3.3 By Type - Global Mucopolysaccharidosis II Sales Market Share, 2016-2027
4.4 By Type - Global Mucopolysaccharidosis II Price (Manufacturers Selling Prices), 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Mucopolysaccharidosis II Market Size, 2021 & 2027
5.1.2 Hospital
5.1.3 Clinic
5.1.4 Research Center
5.1.5 Others
5.2 By Application - Global Mucopolysaccharidosis II Revenue & Forecasts
5.2.1 By Application - Global Mucopolysaccharidosis II Revenue, 2016-2021
5.2.2 By Application - Global Mucopolysaccharidosis II Revenue, 2022-2027
5.2.3 By Application - Global Mucopolysaccharidosis II Revenue Market Share, 2016-2027
5.3 By Application - Global Mucopolysaccharidosis II Sales & Forecasts
5.3.1 By Application - Global Mucopolysaccharidosis II Sales, 2016-2021
5.3.2 By Application - Global Mucopolysaccharidosis II Sales, 2022-2027
5.3.3 By Application - Global Mucopolysaccharidosis II Sales Market Share, 2016-2027
5.4 By Application - Global Mucopolysaccharidosis II Price (Manufacturers Selling Prices), 2016-2027
6 Sights by Region
6.1 By Region - Global Mucopolysaccharidosis II Market Size, 2021 & 2027
6.2 By Region - Global Mucopolysaccharidosis II Revenue & Forecasts
6.2.1 By Region - Global Mucopolysaccharidosis II Revenue, 2016-2021
6.2.2 By Region - Global Mucopolysaccharidosis II Revenue, 2022-2027
6.2.3 By Region - Global Mucopolysaccharidosis II Revenue Market Share, 2016-2027
6.3 By Region - Global Mucopolysaccharidosis II Sales & Forecasts
6.3.1 By Region - Global Mucopolysaccharidosis II Sales, 2016-2021
6.3.2 By Region - Global Mucopolysaccharidosis II Sales, 2022-2027
6.3.3 By Region - Global Mucopolysaccharidosis II Sales Market Share, 2016-2027
6.4 North America
6.4.1 By Country - North America Mucopolysaccharidosis II Revenue, 2016-2027
6.4.2 By Country - North America Mucopolysaccharidosis II Sales, 2016-2027
6.4.3 US Mucopolysaccharidosis II Market Size, 2016-2027
6.4.4 Canada Mucopolysaccharidosis II Market Size, 2016-2027
6.4.5 Mexico Mucopolysaccharidosis II Market Size, 2016-2027
6.5 Europe
6.5.1 By Country - Europe Mucopolysaccharidosis II Revenue, 2016-2027
6.5.2 By Country - Europe Mucopolysaccharidosis II Sales, 2016-2027
6.5.3 Germany Mucopolysaccharidosis II Market Size, 2016-2027
6.5.4 France Mucopolysaccharidosis II Market Size, 2016-2027
6.5.5 U.K. Mucopolysaccharidosis II Market Size, 2016-2027
6.5.6 Italy Mucopolysaccharidosis II Market Size, 2016-2027
6.5.7 Russia Mucopolysaccharidosis II Market Size, 2016-2027
6.5.8 Nordic Countries Mucopolysaccharidosis II Market Size, 2016-2027
6.5.9 Benelux Mucopolysaccharidosis II Market Size, 2016-2027
6.6 Asia
6.6.1 By Region - Asia Mucopolysaccharidosis II Revenue, 2016-2027
6.6.2 By Region - Asia Mucopolysaccharidosis II Sales, 2016-2027
6.6.3 China Mucopolysaccharidosis II Market Size, 2016-2027
6.6.4 Japan Mucopolysaccharidosis II Market Size, 2016-2027
6.6.5 South Korea Mucopolysaccharidosis II Market Size, 2016-2027
6.6.6 Southeast Asia Mucopolysaccharidosis II Market Size, 2016-2027
6.6.7 India Mucopolysaccharidosis II Market Size, 2016-2027
6.7 South America
6.7.1 By Country - South America Mucopolysaccharidosis II Revenue, 2016-2027
6.7.2 By Country - South America Mucopolysaccharidosis II Sales, 2016-2027
6.7.3 Brazil Mucopolysaccharidosis II Market Size, 2016-2027
6.7.4 Argentina Mucopolysaccharidosis II Market Size, 2016-2027
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Mucopolysaccharidosis II Revenue, 2016-2027
6.8.2 By Country - Middle East & Africa Mucopolysaccharidosis II Sales, 2016-2027
6.8.3 Turkey Mucopolysaccharidosis II Market Size, 2016-2027
6.8.4 Israel Mucopolysaccharidosis II Market Size, 2016-2027
6.8.5 Saudi Arabia Mucopolysaccharidosis II Market Size, 2016-2027
6.8.6 UAE Mucopolysaccharidosis II Market Size, 2016-2027
7 Manufacturers & Brands Profiles
7.1 Alexion Pharmaceuticals, Inc.
7.1.1 Alexion Pharmaceuticals, Inc. Corporate Summary
7.1.2 Alexion Pharmaceuticals, Inc. Business Overview
7.1.3 Alexion Pharmaceuticals, Inc. Mucopolysaccharidosis II Major Product Offerings
7.1.4 Alexion Pharmaceuticals, Inc. Mucopolysaccharidosis II Sales and Revenue in Global (2016-2021)
7.1.5 Alexion Pharmaceuticals, Inc. Key News
7.2 AngioChem Inc.
7.2.1 AngioChem Inc. Corporate Summary
7.2.2 AngioChem Inc. Business Overview
7.2.3 AngioChem Inc. Mucopolysaccharidosis II Major Product Offerings
7.2.4 AngioChem Inc. Mucopolysaccharidosis II Sales and Revenue in Global (2016-2021)
7.2.5 AngioChem Inc. Key News
7.3 ArmaGen Inc.
7.3.1 ArmaGen Inc. Corporate Summary
7.3.2 ArmaGen Inc. Business Overview
7.3.3 ArmaGen Inc. Mucopolysaccharidosis II Major Product Offerings
7.3.4 ArmaGen Inc. Mucopolysaccharidosis II Sales and Revenue in Global (2016-2021)
7.3.5 ArmaGen Inc. Key News
7.4 Bioasis Technologies Inc.
7.4.1 Bioasis Technologies Inc. Corporate Summary
7.4.2 Bioasis Technologies Inc. Business Overview
7.4.3 Bioasis Technologies Inc. Mucopolysaccharidosis II Major Product Offerings
7.4.4 Bioasis Technologies Inc. Mucopolysaccharidosis II Sales and Revenue in Global (2016-2021)
7.4.5 Bioasis Technologies Inc. Key News
7.5 Green Cross Corporation
7.5.1 Green Cross Corporation Corporate Summary
7.5.2 Green Cross Corporation Business Overview
7.5.3 Green Cross Corporation Mucopolysaccharidosis II Major Product Offerings
7.5.4 Green Cross Corporation Mucopolysaccharidosis II Sales and Revenue in Global (2016-2021)
7.5.5 Green Cross Corporation Key News
7.6 Inventiva
7.6.1 Inventiva Corporate Summary
7.6.2 Inventiva Business Overview
7.6.3 Inventiva Mucopolysaccharidosis II Major Product Offerings
7.6.4 Inventiva Mucopolysaccharidosis II Sales and Revenue in Global (2016-2021)
7.6.5 Inventiva Key News
7.7 JCR Pharmaceuticals Co., Ltd.
7.7.1 JCR Pharmaceuticals Co., Ltd. Corporate Summary
7.7.2 JCR Pharmaceuticals Co., Ltd. Business Overview
7.7.3 JCR Pharmaceuticals Co., Ltd. Mucopolysaccharidosis II Major Product Offerings
7.4.4 JCR Pharmaceuticals Co., Ltd. Mucopolysaccharidosis II Sales and Revenue in Global (2016-2021)
7.7.5 JCR Pharmaceuticals Co., Ltd. Key News
7.8 Laboratorios Del Dr. Esteve S.A.
7.8.1 Laboratorios Del Dr. Esteve S.A. Corporate Summary
7.8.2 Laboratorios Del Dr. Esteve S.A. Business Overview
7.8.3 Laboratorios Del Dr. Esteve S.A. Mucopolysaccharidosis II Major Product Offerings
7.8.4 Laboratorios Del Dr. Esteve S.A. Mucopolysaccharidosis II Sales and Revenue in Global (2016-2021)
7.8.5 Laboratorios Del Dr. Esteve S.A. Key News
7.9 RegenxBio Inc.
7.9.1 RegenxBio Inc. Corporate Summary
7.9.2 RegenxBio Inc. Business Overview
7.9.3 RegenxBio Inc. Mucopolysaccharidosis II Major Product Offerings
7.9.4 RegenxBio Inc. Mucopolysaccharidosis II Sales and Revenue in Global (2016-2021)
7.9.5 RegenxBio Inc. Key News
7.10 Sangamo BioSciences, Inc.
7.10.1 Sangamo BioSciences, Inc. Corporate Summary
7.10.2 Sangamo BioSciences, Inc. Business Overview
7.10.3 Sangamo BioSciences, Inc. Mucopolysaccharidosis II Major Product Offerings
7.10.4 Sangamo BioSciences, Inc. Mucopolysaccharidosis II Sales and Revenue in Global (2016-2021)
7.10.5 Sangamo BioSciences, Inc. Key News
7.11 Takeda
7.11.1 Takeda Corporate Summary
7.11.2 Takeda Mucopolysaccharidosis II Business Overview
7.11.3 Takeda Mucopolysaccharidosis II Major Product Offerings
7.11.4 Takeda Mucopolysaccharidosis II Sales and Revenue in Global (2016-2021)
7.11.5 Takeda Key News
8 Global Mucopolysaccharidosis II Production Capacity, Analysis
8.1 Global Mucopolysaccharidosis II Production Capacity, 2016-2027
8.2 Mucopolysaccharidosis II Production Capacity of Key Manufacturers in Global Market
8.3 Global Mucopolysaccharidosis II Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Mucopolysaccharidosis II Supply Chain Analysis
10.1 Mucopolysaccharidosis II Industry Value Chain
10.2 Mucopolysaccharidosis II Upstream Market
10.3 Mucopolysaccharidosis II Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Mucopolysaccharidosis II Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Mucopolysaccharidosis II in Global Market
Table 2. Top Mucopolysaccharidosis II Players in Global Market, Ranking by Revenue (2019)
Table 3. Global Mucopolysaccharidosis II Revenue by Companies, (US$, Mn), 2016-2021
Table 4. Global Mucopolysaccharidosis II Revenue Share by Companies, 2016-2021
Table 5. Global Mucopolysaccharidosis II Sales by Companies, (K Pcs), 2016-2021
Table 6. Global Mucopolysaccharidosis II Sales Share by Companies, 2016-2021
Table 7. Key Manufacturers Mucopolysaccharidosis II Price (2016-2021) & (USD/Pcs)
Table 8. Global Manufacturers Mucopolysaccharidosis II Product Type
Table 9. List of Global Tier 1 Mucopolysaccharidosis II Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Mucopolysaccharidosis II Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type

Alexion Pharmaceuticals, Inc.
AngioChem Inc.
ArmaGen Inc.
Bioasis Technologies Inc.
Green Cross Corporation
Inventiva
JCR Pharmaceuticals Co., Ltd.
Laboratorios Del Dr. Esteve S.A.
RegenxBio Inc.
Sangamo BioSciences, Inc.
Takeda

First Name *

Last Name

Country *

E-mail *

Contact No *

Company Name*

Job Title*

Comments

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Have a Question?

EMAIL US

RELATED PRODUCTS

ReportsWeb has an extensive coverage of industry reports, company reports and country reports accross all industries.

View All New Reports

Global Freckle-removing Medical and Beau.. The global market for Freckle-removing Medical and Beauty Eq..

Global Wall Mounted Sinks Market Growth .. The sink is a trough-shaped appliance used to receive kitche..

Global Peripheral Imaging Catheter Marke.. The Peripheral Imaging Catheter's unique design provides exc..

Global Hemostatic Valves and Accessories.. Haemostatic valve prevents blood reflux when a catheter is i..

Global Liver Cancer Treatment Drug Marke.. The global market for Liver Cancer Treatment Drug is estimat..

Global Hypertensive Heart Disease Drug M.. The global market for Hypertensive Heart Disease Drug is est..

Global Urinary Incontinence Drug Market .. The global market for Urinary Incontinence Drug is estimated..

Global Pet Antibiotic Market Growth 2022.. The global market for Pet Antibiotic is estimated to increas..

Global Hemorrhagic Disease Detection Mar.. The global market for Hemorrhagic Disease Detection is estim..

Global Cell Dissociation Solution Market.. The global market for Cell Dissociation Solution is estimate..

Global Cell Detachment and Dissociation .. The global market for Cell Detachment and Dissociation Solut..

Global Cell Detachment Solution Market G.. The global market for Cell Detachment Solution is estimated ..

CUSTOM RESEARCH

ReportsWeb has an extensive coverage of industry reports, company reports and country reports accross all industries.

LEARN MORE